Your browser doesn't support javascript.
loading
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
André, Thierry; Meyerhardt, Jeffrey; Iveson, Timothy; Sobrero, Alberto; Yoshino, Takayuki; Souglakos, Ioannis; Grothey, Axel; Niedzwiecki, Donna; Saunders, Mark; Labianca, Roberto; Yamanaka, Takeharu; Boukovinas, Ioannis; Vernerey, Dewi; Meyers, Jeffrey; Harkin, Andrea; Torri, Valter; Oki, Eiji; Georgoulias, Vassilis; Taieb, Julien; Shields, Anthony; Shi, Qian.
Afiliação
  • André T; Sorbonne Université and Hôpital Saint Antoine, Paris, France.
  • Meyerhardt J; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Iveson T; Department of Medical Oncology, University of Southampton, Southampton, UK.
  • Sobrero A; Medical Oncology Unit, Ospedale San Martino, Genova, Italy.
  • Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Souglakos I; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
  • Grothey A; West Cancer Center and Research Institute, OneOncology, Germantown, TN, USA.
  • Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
  • Saunders M; Christie Hospital, Manchester, UK.
  • Labianca R; Ospdale Papa Giovanni XXIII, Bergamo, Italy.
  • Yamanaka T; Yokohama City University School of Medicine Yokohama, Japan.
  • Boukovinas I; Bioclinic Thessaloniki Medical Oncology Unit, Thessaloniki, Greece.
  • Vernerey D; Methodology and Quality of Life Unit, INSERM UMR 1098, Besançon, France.
  • Meyers J; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.
  • Harkin A; Operations Director, Cancer Research UK Glasgow Clinical Trials Unit, Glasgow, UK.
  • Torri V; IRRCS Mario Negri Institute for Pharmacological Research, Milan, Italy.
  • Oki E; Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
  • Georgoulias V; University of Crete, Rethymnon, Greece.
  • Taieb J; Université de Paris and Department of Gastroenterology and Gastrointestinal Oncology, Georges-Pompidou European Hospital, Paris, France.
  • Shields A; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
  • Shi Q; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA. Electronic address: shi.qian2@mayo.edu.
Lancet Oncol ; 21(12): 1620-1629, 2020 12.
Article em En | MEDLINE | ID: mdl-33271092

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo Tipo de estudo: Clinical_trials / Observational_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo Tipo de estudo: Clinical_trials / Observational_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França